APP and Alzheimer disease: It also lowers ROS production, enhances the cell viability, reverses the mitochondrial membrane potential dissipation, decreases the Aβ1‐42 secretion, downregulates the AβPP level, and increases the SOD activity in AD cell model (Liu et al. 2011).